GenFleet Therapeutics (Shanghai) Inc. held an extraordinary general meeting on February 9, 2026. Shareholders approved the abolishment of the Supervisory Committee and amendments to the Articles of Association.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260209-12019906), on February 09, 2026, and is solely responsible for the information contained therein.